Last Updated: 31-07-2025 | Format: PDF | Report ID:20264 | Author: Abhishek
| Key Market Question | Answer |
|---|---|
| What is the market size in 2025? | $3,400 Million |
| What is the projected market size by 2035? | $4,800 Million |
| What is the market CAGR from 2025 to 2035? | 3.5% |
| Which region dominates the market? | United States (72%) |
| Which product/service type dominates the market? | Reagent & Kits (44%) |
| Which application leads the market? | Blood Transfusion (38%) |
| Who are the major buyers? | Hospitals (49%), Blood Banks (32%) |
| What are the key market growth drivers? | Technological advancements in blood screening; Rising prevalence of infectious diseases and increasing demand for blood transfusions are driving screening activities |
| What are the major market challenges? | Regulatory complexities and prolonged approval timelines for new technologies remain a challenge; Shortages of skilled personnel for operating high-end diagnostic instruments continue to hinder test throughput |
| What is the forecast period? | 2026–2035 |
Study period:
2020-2035
Base year:
2026
Historical data
2020-2024
NO OF PAGE:
167
What You Get:
| Who are the key market players? |
| Abbott Laboratories, Grifols S.A., Bio-Rad Laboratories, F. Hoffmann-La Roche AG, Becton Dickinson and Company, Danaher Corporation, Thermo Fisher Scientific Inc., Siemens Healthineers AG, Ortho Clinical Diagnostics, bioMérieux SA, DiaSorin S.p.A., PerkinElmer Inc., Enzo Biochem Inc., Trinity Biotech Plc, Merck KGaA |
North America Newborn Screening Market: by Type (Blood Tests, Hearing Screening, Pulse Oximetry, Genetic Testing, Critical Congenital Heart Disease Screening, Other Types), Application (Dry Blood Spot Screening, Hearing Screening, Cystic Fibrosis, Sickle Cell Disease, Critical Congenital Heart Disease, Other Applications), Distribution Channels (Hospitals, Diagnostic Centers, Clinics, Laboratories, Specialty Centers, Other Distribution Channels), Technology (Tandem Mass Spectrometry, Immunoassays & Enzymatic Assays, Pulse Oximetry, Molecular Assays, Hearing Screening Technology, Other Technologies), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025
Global Biosimilars Treatment Market: by Type (Monoclonal Antibodies, Recombinant Hormones, Fusion Proteins, Immunomodulators, Insulins, Erythropoietin), Application (Oncology, Autoimmune Diseases, Chronic Diseases, Blood Disorders, Infectious Diseases, Other Applications), Distribution Channels (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Specialty Clinics, Drug Stores, Others), Technology (Recombinant DNA Technology, Monoclonal Antibody Technology, Genomics, Proteomics, Bioengineering, Others), Organization Size (Small, Medium, Large) and By Global – Historical & Forecast Period (2020-2035) Comprehensive Study 2025
Global Residual DNA Testing Market: by Type (qPCR-based Residual DNA Testing, PCR-based Residual DNA Testing, DNA Hybridization, ELISA-based Residual DNA Testing, Others), Application (Biopharmaceuticals, Vaccines, Gene Therapy, Cell Therapy, Blood and Plasma Products, Others), Distribution Channels (Direct Sales, Distributors, Online Sales, Others), Technology (qPCR, PCR, Hybridization, ELISA, Capillary Electrophoresis, Others), Organization Size (Small, Medium, Large) and By Global – Historical & Forecast Period (2020-2035) Comprehensive Study 2025
Global Active Pharmaceutical Ingredient Market: by Type (Synthetic, Biotech, HPAPI, Highly Potent, Generic, Branded), Application (Cardiology, Oncology, Neurology, Endocrinology, Anti-infectives, Others), Distribution Channels (Direct Sales, Distributors/Wholesalers, E-commerce, Specialty Pharmacies, Hospitals, Retail Pharmacies), Technology (Traditional, Biotechnology, Fermentation, Chemical Synthesis, High-Throughput Screening, Others), Organization Size (Small, Medium, Large) and By Global – Historical & Forecast Period (2020-2035) Comprehensive Study 2025
Europe Early Stage Cancer Market Market: by Type (Breast Cancer, Colorectal Cancer, Prostate Cancer, Lung Cancer, Cervical Cancer, Other Cancers), Application (Diagnosis, Treatment, Prognosis, Screening, Research, Others), Distribution Channels (Hospitals, Diagnostic Centers, Research Laboratories, Specialty Clinics, Pharmacies, Online Channels), Technology (Immunotherapy, Targeted Therapy, Chemotherapy, Radiation Therapy, Surgery, Others), Organization Size (Small, Medium, Large) and By Europe Historical & Forecast Period (2020-2035) Comprehensive Study 2025